+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement

Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement

Molecular Neurobiology 54(6): 4486-4495

Interleukin-1 (IL-1), a proinflammatory cytokine synthesized and released by activated microglia, can cause dopaminergic neurodegeneration leading to Parkinson's disease (PD). However, it is uncertain whether IL-1 can act directly, or by exacerbating the harmful actions of other brain insults. To ascertain the role of the IL-1 pathway on dopaminergic neurodegeneration and motor skills during aging, we compared mice with impaired [caspase-1 knockout (casp1-/-)] or overactivated IL-1 activity [IL-1 receptor antagonist knockout (IL-1ra-/-)] to wild-type (wt) mice at young and middle age. Their motor skills were evaluated by the open-field and rotarod tests, and quantification of their dopamine neurons and activated microglia within the substantia nigra were performed by immunohistochemistry. IL-1ra-/- mice showed an age-related decline in motor skills, a reduced number of dopamine neurons, and an increase in activated microglia when compared to wt or casp1-/- mice. Casp1-/- mice had similar changes in motor skills and dopamine neurons, but fewer activated microglia cells than wt mice. Our results suggest that the overactivated IL-1 pathway occurring in IL-1ra-/- mice in the absence of inflammatory interventions (e.g., intracerebral injections performed in animal models of PD) increased activated microglia, decreased the number of dopaminergic neurons, and reduced their motor skills. Decreased IL-1 activity in casp1-/- mice did not yield clear protective effects when compared with wt mice. In summary, in the absence of overt brain insults, chronic activation of the IL-1 pathway may promote pathological aspects of PD per se, but its impairment does not appear to yield advantages over wt mice.

(PDF emailed within 0-6 h: $19.90)

Accession: 058791079

Download citation: RISBibTeXText

PMID: 27356916

DOI: 10.1007/s12035-016-9988-x

Related references

The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134(Pt 11): 3146-3166, 2012

The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: Role of BDNF gene expression. Molecular Brain Research 41(1-2): 16-26, 1996

Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway. Journal of Pineal Research 32(4): 262-269, 2002

The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America 106(19): 8043-8048, 2009

Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Journal of Neuroscience 36(18): 5144-5159, 2017

Experimental oesophagitis in the rat is associated with decreased voluntary movement. Neurogastroenterology and Motility 21(3): 296-303, 2009

Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice. Neuron 96(4): 796-807.E6, 2017

Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway. Redox Biology 14: 250-260, 2017

Accumulation of cholesterol and homocysteine in the nigrostriatal pathway of brain contributes to the dopaminergic neurodegeneration in mice. Neuroscience: -, 2018

The possible role of one-electron reduction of aminochrome in the neurodegeneration of the dopaminergic systems and the neuroprotective role of DT-diaphorase. Journal of Physiology (Cambridge) 525P: 104P, June, 2000

Cell cycle activation in p21 dependent pathway: An alternative mechanism of organophosphate induced dopaminergic neurodegeneration. Biochimica et Biophysica Acta. Molecular Basis of Disease 1863(7): 1858-1866, 2016

Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway. Neurobiology of Aging 69: 117-128, 2018

Inhibition of p38 pathway-dependent MPTP-induced dopaminergic neurodegeneration in estrogen receptor alpha knockout mice. Hormones and Behavior 80: 19-29, 2016

A role for iron deficiency in dopaminergic neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 113(13): 3417-3418, 2016

Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-derived neurotrophic factor. Journal of Neurochemistry 120(6): 1072-1083, 2012